Clinical Trial Update: Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL [Phase 2]

View source ↗

Summary

Phase 2 trial exploring a triple combination of venetoclax, olverembatinib, and prednisolone for Philadelphia chromosome-positive precursor B-cell acute lymphob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Precursor B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Olverembatinib (Olverembatinib)
• Prednisolone (Prednisolone)
• Venetoclax (venetoclax)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Precursor B-Cell Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING